Skip to content

Vestibular Socket Therapy Using Acellular Dermal Matrix Versus Connective Tissue Graft

Vestibular Socket Therapy Using Acellular Dermal Matrix Versus Connective Tissue Graft in Immediate Implants of Aesthetic Zone

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06241196
Enrollment
10
Registered
2024-02-05
Start date
2022-07-01
Completion date
2024-04-01
Last updated
2024-02-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Immediate Implant

Keywords

vestibular socket therapy, dental implant, soft tissue graft

Brief summary

The aim of this study is to evaluate and compare the Vestibular Socket Therapy (VST) technique using alloderm versus connective tissue graft both with xenogenic bone membrane in immediate implants of anterior aesthetic zone.

Detailed description

Twenty surgical sites will be divided into two groups; each of which has 10 surgical sites. Grouping will be done randomly sequentially numbered, opaque, sealed envelopes (SNOSE) The groups will be treated as follow: * Group I: Ten sites will be treated by immediate implant and VST with Alloderm + allogenic bone membrane and xenograft. * Group II: Ten sites will be treated by immediate implant and VST with connective tissue graft + allogenic bone membrane and xenograft Each group will be subjected to intraoral scanning at baseline, 6 months and 12 months. The changes in peri-implant mucosal level will be assessed by superimposition of scanning files of different intervals to monitor the changes in surface area calculated by software. The changes in gingival phenotype could be assessed at 6 months and 12 months intervals by superimposition of DICOM files on CBCT software Each group will be subjected to Cone Beam Computed Tomography (CBCT) at baseline, 6 months and 12months to asses both thickness and height of labial (facial) plate of bone and implant survival.

Interventions

DEVICEimplant

Implant will be placed through the surgical guide in the extraction socket

tunnel incision will be made in labial vestibule

allogenic soft tissue substitute

DRUGXenogenic bone membrane shield

xenogenic bone membrane

PROCEDUREConnective tissue graft

soft tissue harvesting from palate

Sponsors

Tanta University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Caregiver, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
20 Years to 50 Years
Healthy volunteers
No

Inclusion criteria

* Adults (20-50) years old. * Class II socket according to Elian et al, (7)described as facial soft tissue is present but the buccal plate is partially missing following extraction of the tooth in the maxillary anterior region. * Thin gingival phenotype. * Bone quality ranges from D2-D3 as gained from preoperative cone beam computed tomography. * Presence of at least 3 mm of keratinized gingiva. * Optimal compliance as evidenced by no missing treatment appointments and positive attitude towards oral hygiene.

Exclusion criteria

* Medically compromised patients and systemic conditions precluding implant and periodontal surgery. * Smokers, diabetics, pregnant or lactating women. * History of chemotherapy, radiotherapy in head and/or neck region. * Bisphosphonate therapy.

Design outcomes

Primary

MeasureTime frameDescription
changes in peri-implant mucosal levelbaseline, 6, 12 monthslevel of peri-implant mucosa
changes in gingival phenotypebaseline, 6, 12 monthsthickness of peri-implant mucosa

Secondary

MeasureTime frameDescription
thickness of labial (facial) plate of bonebaseline, 6, 12 monthsthree area measures of facial bone
implant survivalbaseline, 6, 12 monthsimplant stability, health, mobility and function
height of labial (facial) plate of bonebaseline, 6, 12 monthsApico-coronal height of labial bone

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026